Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06610500
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-20
Brief Title:
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Clozapine is a drug that requires regular and diligent hematological monitoring throughout its use This follow-up is in France framed by a compulsory paper format of the blood count follow-up notebook for each patient Due to the multiplicity of the different modes of transmission of the different documents necessary for compliance with the regulations for the prescription dispensing and administration of clozapine we decided to carry out a current inventory in the department of Loire with respect for the latter The main objective of this study is to assess the rate of non-compliance in circuits of prescription dispensing and administration of clozapine by sending a questionnaire on habits of prescriptions dispensing and administration of health professionals psychiatrists pharmacists and by sending a questionnaire to the patients treated by clozapine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None